Synata Bio
PrivateLast Round
Grant
Nov 19, 2024
Total Funding Raised
$324M
Company Overview
Synata Bio is an industrial chemicals company that develops fermentation technology to convert waste gases and synthesis gas into ethanol and other chemical products.
Sector
Energy & Sustainability
Verticals
Carbon Capture, Circular Economy, Alternative Fuels, Clean Manufacturing, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synata Bio Comparables
Compare Synata Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jupeng Bio | 84% | |
| Phase Biolabs | 81% | |
| LanzaTech | 80% |
Synata Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2024 | ||||
| Series D | Aug 22, 2011 | ||||
| Debt | Jan 20, 2011 | ||||
| Series C Extension | Apr 29, 2010 | ||||
| Series C | Dec 8, 2008 | ||||
Series B | Mar 21, 2008 |
Synata Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series B, Series A, Series C |
| Blackstone | Series D, Series C |
| Khosla Ventures | Series B, Series C Extension, Series A, Series D, Series C |
| TotalEnergies Carbon Neutrality Ventures | Series D |
| National Development and Reform Commission | Grant |
| Advanced Technology Ventures | Series B, Series C Extension, Series A, Series C |
| Sumitomo Corporation | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 247% MoM, reaching 4.2K.
- May 2, 2025
Monthly visitors increased 68% MoM.
Synata Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synata Bio's valuation, stock price, and market status.
Is Synata Bio a public or private company?
Synata Bio is a private company.
What is the current stock price of Synata Bio?
Synata Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Synata Bio worth (valuation)?
Valuation information for Synata Bio is not publicly available.
Can I buy Synata Bio stock?
Synata Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Synata Bio's last funding round?
Synata Bio's most recent funding round was Grant on November 19, 2024.
Who are the main investors in Synata Bio?
Key investors in Synata Bio include Blackstone.
Will Synata Bio IPO soon?
No public IPO plans have been announced for Synata Bio.
How can I track Synata Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synata Bio's secondary market activity and sign up for updates.